News

Ascendis Pharma A/S to Participate in the BofA Securities 2022 Healthcare Conference

COPENHAGEN, Denmark, May 09, 2022 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) announced today that the company is scheduled…

2 years ago

Humacyte to Provide Human Acellular Vessels™ (HAVs™) to Front-line Hospitals in Ukraine for Treatment of Vascular Trauma Injuries

-- First shipment of HAVs to six Ukrainian hospitals made today -- -- Product candidate to be used for civilian…

2 years ago

Imago BioSciences Announces First Participant Dosed in Investigator-Sponsored Study of Bomedemstat in Combination with Atezolizumab in Small Cell Lung Cancer

SOUTH SAN FRANCISCO, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Imago BioSciences, Inc. (“Imago”) (Nasdaq: IMGO), a clinical stage biopharmaceutical company…

2 years ago

Immix Biopharma Announces Share Repurchase Program

Immix Biopharma Announces Share Repurchase Program Immix Biopharma, Inc. (NASDAQ:IMMX)LOS ANGELES, May 09, 2022 (GLOBE NEWSWIRE) -- Immix Biopharma, Inc.…

2 years ago

Alimera Sciences Reports First Quarter 2022 Results

Consolidated Net Revenue of $11.9 Million Up 6% vs. First Quarter of 2021U.S. Net Revenue Increased 23% vs. First Quarter…

2 years ago

Aadi Bioscience Announces Collaborations with Next Generation Sequencing Leaders

Company enters into collaborations with leading next generation sequencing (NGS) companies to facilitate trial enrollment for PRECISION 1, the Company’s…

2 years ago

Synthetic Biologics to Host Conference Call and Webcast to Discuss First Quarter 2022 Operational Highlights and Financial Results

ROCKVILLE, Md., May 09, 2022 (GLOBE NEWSWIRE) -- Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company developing therapeutics…

2 years ago

Apexigen to Host Investor Day on Antibody Therapeutic Pipeline and Unique APXiMAB™ Platform

-Webinar to be held Monday, May 16th at 8:00 a.m. PT/ 11:00 a.m. ET-SAN CARLOS, Calif., May 09, 2022 (GLOBE…

2 years ago

Eledon Pharmaceuticals Announces First Patient Dosed in Phase 2a Trial Evaluating Tegoprubart in IgA Nephropathy

Initial data from openPhase 2a study expected in late 2022IRVINE, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- Eledon…

2 years ago

PetMeds® Hires Pet-Industry Veteran into Pivotal Leadership Role

In her new role as VP of Product Management, Carolyn Carden will scale PetMeds’ product portfolio, including its rapidly growing…

2 years ago